Mark Bradley Moseley Jr. - 11 Dec 2023 Form 4 Insider Report for PETMED EXPRESS INC (PETS)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
12 Dec 2023, 16:55:12 UTC
Prior SEC filing
23 May 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Mark Moseley Jr.

Key filing fact

Mark Bradley Moseley Jr. filed Form 4 for PETMED EXPRESS INC (PETS) on 12 Dec 2023.

Key facts

  • This page summarizes Mark Bradley Moseley Jr.'s Form 4 filing for PETMED EXPRESS INC (PETS).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 12 Dec 2023, 16:55.

Change

  • Previous filing in this sequence was filed on 23 May 2023.
  • Current net transaction value: +$99,960.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PETS transaction

Common Stock

Award

Transaction value
$99,960
Shares
+14,000
Change %
+50%
Price
$7.14
Shares after
42,000
Date
11 Dec 2023
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Includes 14,000 shares of restricted stock under the Company's 2022 Employee Equity Compensation Plan, which stock restrictions will lapse pro rata in one-third increments on each of December 1, 2024, December 1, 2025, and December 1, 2026, subject to forfeiture in the event of termination of employment. Mr. Moseley retains voting rights over all the shares subject to forfeiture while in escrow.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .